Testing slow steroid taper versus stopping suddenly
Treatments studied
Part of Immune system & allergy clinical trials.
This trial studies whether it’s safer or works better to slowly reduce steroids versus stopping them abruptly after long-term use. It may help people who are currently on daily steroid tablets and don’t medically need a taper just to treat their underlying condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have been taking daily steroid tablets (glucocorticoids) for at least 28 days
- Have a steroid dose of at least 7.5 mg prednisone-equivalent per day on average
- Have taken at least 420 mg total prednisone-equivalent over time before joining
- Your doctor does not require tapering for your original disease (tapering is not or is no longer mandatory)
- Be able and willing to give informed consent and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
This study compares two different schedules for reducing prednisone (a steroid) in people with rheumatoid arthritis who are also taking another standard arthritis medicine. The goal is to find the safest and most effective way to taper off steroids without causing a flare-up.
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
This study compares two different ways of slowly lowering the dose of steroids (like prednisolone) in people with stable rheumatoid arthritis. The goal is to see which tapering schedule is safer and more effective, possibly reducing side effects while keeping the disease under control.
This trial compares two steroid medicines (hydrocortisone and methylprednisolone) to see which one works better for people whose adrenal glands have stopped working properly after taking high doses of steroids for a long time. It aims to find the safest and most effective way to replace the missing hormones.
This trial tests if people with stable sarcoidosis can safely lower their corticosteroid dose over time. It may help reduce side effects from long-term steroid use.
Hear when a new Autoimmune trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.